Angiocrine Bioscience, Inc.

Biotechnology company · San Diego, California, United States

Angiocrine Bioscience, Inc. is a biotechnology company headquartered in San Diego, California, United States. Its earliest recorded incorporation is in 2012. It has reported private securities offerings to the US SEC, most recently $2.1 million sold in a notice filed in 2025.

Profile compiled from public records. Is this your company? Request a correction or update

Angiocrine Bioscience at a glance

Typebiotechnology company

HeadquartersSan Diego, California, United States

Earliest incorporation on record2012

SEC CIK1569052

What does Angiocrine Bioscience do?

Private fundraising reported to the SEC

3 Form D notices; the most recent reported $2.1 million sold (2025).

Frequently asked questions about Angiocrine Bioscience

Where is Angiocrine Bioscience headquartered?

Angiocrine Bioscience, Inc. is headquartered in San Diego, California, United States.

What does Angiocrine Bioscience do?

Angiocrine Bioscience, Inc. is a biotechnology company.

When was Angiocrine Bioscience founded?

The earliest incorporation on record for Angiocrine Bioscience, Inc. is in 2012, according to public company registers.

Similar companies

BioAtla, Inc.San Diego, California, United States
Neurocrine Biosciences IncSan Diego, California, United States
ImmunityBio, Inc.San Diego, California, United States
Sorrento Therapeutics, Inc.San Diego, California, United States
Protego Biopharma, Inc.San Diego, California, United States
Tempo Therapeutics, Inc.San Diego, California, United States
Fate Therapeutics IncSan Diego, California, United States
ImageneBio, Inc.San Diego, California, United States

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences